FDA Grand Rounds presented by the Office of Women’s Health: FDA Menopausal Hormone Therapy (MHT) Labeling: Historical Context and Recent Changes
Nicholas Hazen, M.D. · Center for Drug Evaluation and Research, U.S. Food and Drug Administration
We use cookies for analytics.
2 seminarsNewest first